Greenwich LifeSciences, Inc. (GLSI) NASDAQ

10.91

+0.26(+2.44%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap146.15M
Enterprise Value142.06M
P/E Ratio-8.11
PEG Ratio1.02
Price/Sales Ratio41,170.02
Price/Book Ratio101.34
Enterprise/Revenue40,304.82
Enterprise/EBITDA-8.05

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-4,981.33
Operating Margin-5,022.56

Management Effectiveness

Return On Assets-5.76
Return On Equity-7.01

Income Statement

Revenue0
Revenue/Share0
Gross Profit-3,612
EBITDA-15.79M
Net Income-15.79M
Diluted EPS-1.21

Balance Sheet

Total Cash3.13M
Total Cash/Share0.23
Total Debt0
Total Debt/Equity0
Current Ratio1.85
Book Value Per Share0.11

Price History

52-Week Change-20.13
52-Week High15.47
52-Week Low8.06
Moving Average 50 Days11.42
Moving Average 200 Days11.03

Statistics

Average Volume69,761
Shares Outstanding13.63M
% Held by Institutions9.03

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A